Skip to content

Clinical trials

Phase 3 Carcinoma trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 3 Country / region: New Zealand Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20121
20131
20161
20181
20193
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Exelixis2
Abbott1
Australasian Gastro-Intestinal Trials Group1
Daiichi Sankyo1
Queensland Centre for Gynaecological Cancer1
Trans Tasman Radiation Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma10
Neoplasms4
Adenocarcinoma3
Carcinoma, Hepatocellular3
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Digestive System Diseases1
Digestive System Neoplasms1
Endometrial Neoplasms1
Liver Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.